Syndromic surveillance - overdose

Syndromic surveillance is near-real-time monitoring of indicators using automated data acquisition, processing and statistical alerts. Surveillance data can be used to monitor and detect changes in frequency and guide preventive measures in an attempt to reduce or eliminate morbidity and mortality.

Overdose is common among persons who use illicit opioids such as heroin, and among those who misuse medications prescribed for pain such as oxycodone, hydrocodone, methadone, buprenorphine, and morphine. You can use syndromic surveillance to monitor overdose trends in near real-time and provide much-needed information to public health officials.

    1. Do one of the following.

      • (If you are already working in the ESO Suite) Click the Home icon in the upper left corner of the screen.

        1. In a web browser, go to https://www.esosuite.net/EsoSuite.

          The ESO Suite login screen appears.

        2. Enter your user name, password, and agency name, then click Let's Go.

          If MFA is enabled, the Multi-factor authentication dialog box appears, displaying one or more methods you can use to verify your login credentials. The number of methods that appear in the dialog box depends on what MFA methods your ESO Suite administrators enabled in the Admin module.

          Click graphics
          to open them.

          Information on enabling MFA and specific MFA methods is available in the Admin module online help, in Configure multiple-factor authentication.

          Note: If your ESO Suite administrators have disabled MFA ("opted-out"), this dialog does not appear.

        3. (If the Multi-factor authentication dialog box appears) Depending on which buttons appear in the dialog box, verify your login in one of the following ways.

          1. Click MFA verification via authenticator app.

            The dialog box updates with boxes for entering the numbers of the authentication code, and the ESO Suite sends an authentication code to the authenticator application installed on your device.

          2. Open your authenticator application and note the authentication code currently displayed.

          3. Enter the authentication code displayed in the authenticator application.

          4. Click Log In.

          SMS

          1. Click MFA verification via SMS.

            The dialog box updates with boxes for entering the numbers of the authentication code, and the ESO Suite sends an authentication code to the phone number recorded in your PM records and identified with MFA codes.

          2. Enter the authentication code sent to your MFA-registered phone number.

          3. Click Log In.

          1. Click MFA verification via email.

            The dialog box updates with boxes for entering the numbers of the authentication code, and the ESO Suite sends an authentication code to your agency or department email address, recorded in your PM records.

          2. Enter the authentication code sent to your agency or department email address.

          3. Click Log In.

      The ESO Suite landing screen appears.

      Click graphics
      to open them.

      Note: If MFA is enabled, you can access and manage your MFA options through the PM module, on the Settings > Account page, as described in Manage a user account. If your agency or department has enabled MFA but has not purchased the full-featured version of the PM module, you can access your own MFA settings by clicking Change my Multi-Factor Authentication settings on the landing screen, then using the Settings > Account page that appears. If your agency has not enabled MFA, the Change my Multi-Factor Authentication settings link does not appear on the landing screen.

    2. On the top side of the home screen, click EHR.

      Tip: If your screen or browser window is too narrow to display all your agency's ESO Suite module icons, an options icon appears on the right side of the icon bar. If you click the options icon, a menu appears containing additional module icons.

      The EHR screen appears, displaying a list of patient records in the EHR module. The most-recent records appear at the top of the list.

      Different record status icons can appear in the list.

      Icon Status

      Unlocked/Draft

      The patient record exists in the ESO Suite database, and all crew members listed in the patient record may edit all fields in the record. ESO Suite administrators and personnel with security roles of either EHR Supervisor or EHR Manager can edit non-clinical fields.

      Mobile

      The patient record exists on the mobile device, and has not been synchronized with the ESO Suite database. ESO Suite administrators, personnel with security roles of either EHR Supervisor or EHR Manager, and all crew members listed in the patient record can only access a print view of the record.

      Once the Mobile record synchronizes with the ESO Suite database. the record reflects its current status.

      Locked

      The patient record exists in the ESO Suite database, and is locked. Only non-clinical fields can be edited by crew members listed in the patient record, ESO Suite administrators and personnel with security roles of either EHR Supervisor or EHR Manager.

  2. Information on adding or opening a patient record is available in Add a patient record and Search for a patient record.

    The patient record opens and displays the Incident tab, with the Response bookmark selected in the left pane. Fields appear in the right pane for specifying basic information about the incident

    If you manually created a new patient record, the Incident Number and State Tracking Number fields populate automatically with ESO Suite-assigned values. You must enter data in all other required fields.

    If you imported data from a CAD system, the Incident Number field populates with the data from that source. Other fields in the EHR module may also populate from these sources, depending on what data was recorded in them before the data was imported into the EHR module.

  3. At the top of the page, click the Forms tab.

    The contents of the Forms tab appear, listing all the forms your ESO Suite administrator has enabled in the Admin module.

  4. Click Syndromic Surveillance - Overdose.

    The Syndromic Surveillance - Overdose dialog box appears, with the Times bookmark selected in the left pane.

    1. For Time Performed, click the number pad icon to the right of the field, then enter the appropriate numerical values from the number pad dialog box that appears for the time you evaluated the patient for overdose.

    2. For Date, click the calendar icon on the right end of the field and select the appropriate date from the calendar that appears for the date you evaluated the patient for overdose.

    3. For Onset Time, click the number pad icon to the right of the field, then enter the appropriate numerical values from the number pad dialog box that appears for the time someone noticed the patient experiencing overdose symptoms.

    4. For Date, click the calendar icon on the right end of the field and select the appropriate date from the calendar that appears for the date someone noticed the patient experiencing overdose symptoms.

  6. Common signs of drug overdoses include vomiting, confusion, and being unresponsive. Symptoms can include slowed breathing, erratic pulse, and chest pains.

    1. In the left pane, click the Details bookmark.

      The right pane scrolls down to the top of the Details section of the page.

      1. For Source of Substance, click the list icon to the right of the field, select all the appropriate options from the menu that appears, then click OK or click outside the menu to identify where the drug came from.

        Depending on the options you choose, the Name of Illicit Substance or Name of Legal Substance fields appears.

      2. (If it appears) In Name of Illicit Substance, type the street name(s) of the drug the patient may have overdosed on.

      3. (If it appears) For Name of Legal Substance, click the field or the list icon to the right of the field, then select the appropriate single option from the menu that appears to identify the drug the patient may have overdosed on.

      1. For Method of consumption, click the list icon to the right of the field, select all the appropriate options from the menu that appears, then click OK or click outside the menu to identify how the patient consumed the drug.

        Depending on the options you select, the Estimated Amount Consumed and Measure fields may appear.

      2. For Estimated Consumption Time, click the number pad icon to the right of the field, then enter the appropriate numerical values from the number pad dialog box that appears for the time the patient consumed the drug.

      3. For Date, click the calendar icon on the right end of the field and select the appropriate date from the calendar that appears for the time the patient consumed the drug.

      4. (If it appears) For Estimated Amount Consumed, click the number pad icon to the right of the field, then enter the appropriate numerical values from the number pad dialog box that appears to indicate how much of the drug the patient consumed.

      5. For Measure, click the field or the list icon to the right of the field, then select the appropriate single option from the menu that appears to indicates the units for the amount entered in Estimated Amount Consumed.

    4. For Overdose Reason, click either Suicide Attempt or Unintentional to identify how the overdose occurred.

    5. For Reason Naloxone/Narcan Not Administered, click the list icon to the right of the field, select all the appropriate options from the menu that appears, then click OK or click outside the menu to indicate why opiate-mediating medication was not administered to the patient.

    6. For Naloxone/Narcan Kit left with patient/family member/associate, click the field or the list icon to the right of the field, then select the appropriate single option from the menu that appears to indicate whether or not the patient has access to an opiate-medicating medication after responding personnel left.

    7. From Rehab, click the field or the list icon to the right of the field, then select the appropriate single option from the menu that appears to indicate the patient's willingness to enroll or re-enroll in a dug rehabilitation program.

  7. Click OK.

    The dialog box closes, and a green triangle appears in the upper right corner of the form button, to indicate that data exists in this form.